NZ536402A - 6,11 bicyclic erythromycin derivatives - Google Patents

6,11 bicyclic erythromycin derivatives

Info

Publication number
NZ536402A
NZ536402A NZ536402A NZ53640203A NZ536402A NZ 536402 A NZ536402 A NZ 536402A NZ 536402 A NZ536402 A NZ 536402A NZ 53640203 A NZ53640203 A NZ 53640203A NZ 536402 A NZ536402 A NZ 536402A
Authority
NZ
New Zealand
Prior art keywords
compound
formula
taken together
attached
carbon atom
Prior art date
Application number
NZ536402A
Other languages
English (en)
Inventor
Yat Sun Or
Guoqiang Wang
Ly Tam Phan
Deqiang Niu
Nha Huu Vo
Yao-Ling Qiu
Jay Judson Farmer
Ying Hou
Original Assignee
Enanta Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Enanta Pharm Inc filed Critical Enanta Pharm Inc
Priority claimed from PCT/US2003/014914 external-priority patent/WO2003095466A1/en
Publication of NZ536402A publication Critical patent/NZ536402A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
NZ536402A 2002-05-13 2003-05-13 6,11 bicyclic erythromycin derivatives NZ536402A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14439602A 2002-05-13 2002-05-13
PCT/US2003/014914 WO2003095466A1 (en) 2002-05-13 2003-05-13 6,11 bicyclic erythromycin derivatives
US10/436,622 US7129221B2 (en) 2002-05-13 2003-05-13 6,11-bicyclic erythromycin derivatives

Publications (1)

Publication Number Publication Date
NZ536402A true NZ536402A (en) 2006-08-31

Family

ID=34067652

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ536402A NZ536402A (en) 2002-05-13 2003-05-13 6,11 bicyclic erythromycin derivatives

Country Status (6)

Country Link
US (1) US7129221B2 (enExample)
EP (1) EP1509538A1 (enExample)
JP (1) JP2005536465A (enExample)
KR (1) KR100661973B1 (enExample)
CN (1) CN1659178A (enExample)
NZ (1) NZ536402A (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6841664B2 (en) * 2002-07-25 2005-01-11 Enanra Pharmaceuticals, Inc. 6,11-4-carbon bridged ketolides
US7273853B2 (en) * 2002-05-13 2007-09-25 Enanta Pharmaceuticals, Inc. 6-11 bicyclic ketolide derivatives
US7910558B2 (en) * 2002-05-13 2011-03-22 Enanta Pharmaceuticals, Inc. Bridged macrocyclic compounds and processes for the preparation thereof
US7135573B2 (en) * 2002-05-13 2006-11-14 Enanta Pharmaceuticals, Inc. Processes for the preparation of O-(6-Pyrazol-1-yl-pyridin-3-ylmethyl)-hydroxylamine
TW200420573A (en) * 2002-09-26 2004-10-16 Rib X Pharmaceuticals Inc Bifunctional heterocyclic compounds and methods of making and using same
AU2004217919A1 (en) * 2003-03-05 2004-09-16 Rib-X Pharmaceuticals, Inc. Bifunctional heterocyclic compounds and methods of making and using the same
WO2005042554A1 (en) * 2003-10-30 2005-05-12 Rib-X Pharmaceuticals, Inc. Bifunctional macrolide heterocyclic compounds and methods of making and using the same
US20070270357A1 (en) * 2003-11-18 2007-11-22 Farmer Jay J Bifunctional Macrolide Heterocyclic Compounds and Methods of Making and Using the Same
US7414030B2 (en) * 2004-01-07 2008-08-19 Enanta Pharmaceuticals, Inc. 6-11 Bicyclic erythromycin derivatives
WO2005070113A2 (en) * 2004-01-09 2005-08-04 Enanta Pharmaceuticals, Inc. 9n-substituted 6-11 bicyclic erythromycin derivatives
US7384921B2 (en) * 2004-02-20 2008-06-10 Enanta Pharmaceuticals, Inc. Polymorphic forms of 6-11 bicyclic ketolide derivatives
EP1723159B1 (en) * 2004-02-27 2019-06-12 Melinta Therapeutics, Inc. Macrocyclic compounds and methods of making and using the same
US20060058247A1 (en) * 2004-09-16 2006-03-16 Yujiro Hata Methods and compositions for treating cystic fibrosis
CA2598139A1 (en) * 2005-02-21 2006-08-24 Alpharma Aps Method for the production of macrolides
US7384922B2 (en) * 2005-05-04 2008-06-10 Enanta Pharmaceuticals, Inc. 6-11 bridged oxime erythromycin derivatives
US20060264386A1 (en) * 2005-05-17 2006-11-23 Rongqi Sun Pharmaceutical formulations of 6-11 bicyclic ketolide derivatives and related macrolides and methods for preparation thereof
JP2009539866A (ja) * 2006-06-05 2009-11-19 オースペックス・ファーマシューティカルズ・インコーポレイテッド 置換エリスロマイシンアナログの調製および有用性
US8273720B2 (en) * 2007-09-17 2012-09-25 Enanta Pharmaceuticals, Inc. 6,11-bicyclolides: bridged biaryl macrolide derivatives
US8354383B2 (en) * 2007-09-17 2013-01-15 Enanta Pharmaceuticals, Inc. 6,11-bridged biaryl macrolides
EP2203435B1 (en) * 2007-09-17 2018-07-18 Enanta Pharmaceuticals, Inc. 6, 11-bridged biaryl macrolides
US20090131343A1 (en) * 2007-11-15 2009-05-21 Ly Tam Phan Use of bridged macrolides or tylosin derivatives in treating inflammatory bowel diseases
WO2009137787A1 (en) 2008-05-09 2009-11-12 Enanta Pharmaceuticals, Inc. Processes for the preparation of 2-fluoro 6-11 bicyclic erythromycin derivatives
WO2009137739A1 (en) * 2008-05-09 2009-11-12 Enanta Pharmaceuticals, Inc. Processes for the preparation of o-[5-[4-amino-thiazol-2-yl]-pyridin-2-ylmethyl]-hydroxylamine
TW200946109A (en) * 2008-05-09 2009-11-16 Enanta Pharm Inc Anti-bacterial activity of 9-hydroxy derivatives 6, 11-bicyclolides
WO2010096051A1 (en) * 2009-02-18 2010-08-26 Enanta Pharmaceuticals, Inc. 6,11-bicyclolides: bridged biaryl amide macrolide derivatives
US10118890B2 (en) 2014-10-10 2018-11-06 The Research Foundation For The State University Of New York Trifluoromethoxylation of arenes via intramolecular trifluoromethoxy group migration
CN116947687B (zh) * 2022-04-14 2025-07-18 帕潘纳(北京)科技有限公司 吡唑类除草剂中间体及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR960000434B1 (ko) 1986-12-17 1996-01-06 다이쇼 세이야꾸 가부시끼가이샤 에리스로마이신 a유도체 및 그의 제조 방법
IL99995A (en) 1990-11-21 1997-11-20 Roussel Uclaf Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
EP0559896B1 (en) 1990-11-28 1997-08-27 Taisho Pharmaceutical Co. Ltd 6-o-methylerythromycin a derivative
ATE135707T1 (de) 1992-04-22 1996-04-15 Taisho Pharmaceutical Co Ltd 5-0-desosaminylerythronolid a derivate
US5527780A (en) 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
FR2738571B1 (fr) 1995-09-11 1997-10-17 Roussel Uclaf Nouveaux derives de la 5-0-desosaminyl 6-0-methyl- erythronolide a, leur procede de preparation et leur application a la preparation de produits biologiquement actifs
UA51730C2 (uk) 1996-09-04 2002-12-16 Ебботт Лабораторіз 6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців
CO4990972A1 (es) 1997-10-29 2000-12-26 Abbott Lab Derivados de eritromicina en puente 6,11
US6124269A (en) 1997-10-29 2000-09-26 Abbott Laboratories 2-Halo-6-O-substituted ketolide derivatives
US6046171A (en) 1997-10-29 2000-04-04 Abbott Laboratories 6,11-bridged erythromycin derivatives
CA2370743A1 (en) 1999-04-16 2000-10-26 Dennis Hlasta Ketolide antibacterials
US6878691B2 (en) * 2002-05-13 2005-04-12 Enanta Pharmaceuticals, Inc. 6-11 bicyclic ketolide derivatives

Also Published As

Publication number Publication date
US20040053861A1 (en) 2004-03-18
KR20050003454A (ko) 2005-01-10
JP2005536465A (ja) 2005-12-02
CN1659178A (zh) 2005-08-24
EP1509538A1 (en) 2005-03-02
US7129221B2 (en) 2006-10-31
KR100661973B1 (ko) 2006-12-28

Similar Documents

Publication Publication Date Title
NZ536402A (en) 6,11 bicyclic erythromycin derivatives
PT1506214E (pt) Derivados de cetólido 6-11 bicíclicos
EP1506214B1 (en) 6-11 bicyclic ketolide derivatives
CA2483875C (en) 6,11 bicyclic erythromycin derivatives
WO2005061525A1 (en) 6-11 bicyclic ketolide derivatives
AU2003239403A2 (en) 6-11 bicyclic ketolide derivatives
US7229972B2 (en) 3,6-Bicyclolides
US20050187169A1 (en) 6-11 Bicyclic erythromycin derivatives
US7291602B2 (en) 11,12-lactone bicyclolides
US7276487B2 (en) 9a, 11-3C-bicyclic 9a-azalide derivatives
US7312201B2 (en) Tetracyclic bicyclolides
US20080027012A1 (en) Bridged carbamate macrolides
WO2007044927A2 (en) 6, 11-bridged tricyclic macrolides
WO2006078450A1 (en) 9a, 11-2c-bicyclic 9a-azalide derivatives
US6765016B1 (en) Bicyclic ketolide derivatives
US20070259822A1 (en) 8a,11-bicyclic 8a-azalide derivatives
US7407942B2 (en) 3,6-bridged 9,12-oxolides
WO2008019240A2 (en) 3, 6-bridged tylosin derivatives
WO2008061189A1 (en) C-9 alkenylidine bridged macrolides
WO2005067919A1 (en) 11-csubsituted erythromycin derivatives
US6790835B1 (en) Bicyclic macrolide derivatives
WO2006119384A1 (en) Spirocyclic bicyclolides
WO2005061526A1 (en) 6-11 bicyclic ketolide drivatives
HK1074447B (en) 6-11 bicyclic ketolide derivatives
WO2006119313A2 (en) 6-11 bridged oxime erythromycin derivatives

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 13 MAY 2016 BY ANDY BREEDEN

Effective date: 20130529

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 13 MAY 2017 BY CPA GLOBAL

Effective date: 20160422

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 13 MAY 2018 BY CPA GLOBAL

Effective date: 20170418

LAPS Patent lapsed